A Study of TAK-659 in Combination With Venetoclax for Adult Participants With Previously Treated Non-Hodgkin Lymphoma
Clinical trial NCT03357627 · COMPLETED
Trial details
- NCT number
- NCT03357627
- Sponsor
- Calithera Biosciences, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-16
- Primary completion
- 2021-08-03
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.